P-002 - VIRAL KINETIC MECHANISTIC MODELING OF THE FIRST-IN-CLASS ONCOLYTIC VIRUS THERAPY TALIMOGENE LAHERPAREPVEC (TVEC) IN SUBJECTS WITH ADVANCED MELANOMA.
M. Ahamadi1, A. Narayanan1, P. Chen1, J. Kast2, S. Dutta1, V. Upreti3; 1Amgen Inc., Thousand Oaks, CA, USA, 2Amgen Inc., San Francisco, CA, USA, 3Amgen Inc., South San Francisco, CA, USA.